Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2020 1
2021 2
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of SARS-CoV-2 Antibody Response Post Third Dose COVID-19 mRNA Vaccination at Universitas Indonesia Hospital.
Hidayat R, Mustika AP, Avisha F, Djuliannisaa Z, Winari DD, Putri RA, Lisman HM, Davin V, Fathi GC, Widhani A, Aini MH, Yudhistira Y, Azizah S, Rahmadani M, Istanti ND, Giantini A. Hidayat R, et al. Among authors: giantini a. Acta Med Acad. 2022 Aug;51(2):69-78. doi: 10.5644/ama2006-124.374. Acta Med Acad. 2022. PMID: 36317998 Free PMC article.
Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series.
Hidayat R, Diafiri D, Zairinal RA, Arifin GR, Azzahroh F, Widjaya N, Fani DN, Mesiano T, Kurniawan M, Al Rasyid, Giantini A, Haris S. Hidayat R, et al. Among authors: giantini a. Curr Neurovasc Res. 2021;18(3):360-363. doi: 10.2174/1567202618666210927095613. Curr Neurovasc Res. 2021. PMID: 34579636 Free PMC article.
Surveillance of Adverse Events Following Immunization (AEFI) after Third Dose Booster Vaccination with mRNA-Based Vaccine in Universitas Indonesia Hospital Health Personnel.
Hidayat R, Mustika AP, Avisha F, Djuliannisaa Z, Winari DD, Putri RA, Lisman HM, Davin V, Widhani A, Aini MH, Rahmadani M, Istanti ND, Giantini A. Hidayat R, et al. Among authors: giantini a. Vaccines (Basel). 2022 May 30;10(6):877. doi: 10.3390/vaccines10060877. Vaccines (Basel). 2022. PMID: 35746485 Free PMC article.
Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
Sukmawan R, Hoetama E, Suridanda Danny S, Giantini A, Listiyaningsih E, Gilang Rejeki V, Aziz Alkatiri A, Firdaus I. Sukmawan R, et al. Among authors: giantini a. Pharmacol Res Perspect. 2021 Apr;9(2):e00738. doi: 10.1002/prp2.738. Pharmacol Res Perspect. 2021. PMID: 33641235 Free PMC article.
The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention.
Giantini A, Timan IS, Dharma R, Sukmawan R, Setiabudy R, Alwi I, Harahap AR, Listiyaningsih E, Partakusuma LG, Tansir AR, Sahar W, Hidayat R. Giantini A, et al. Front Cardiovasc Med. 2023 Feb 8;9:1027892. doi: 10.3389/fcvm.2022.1027892. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36843628 Free PMC article.
11 results